Aishwarya Kulkarni

Aishwarya Kulkarni

Auto-generated profile, based on publicly available information

Aishwarya Kulkarni

Peter MacCallum Cancer Centre, Melbourne, VIC, 3000, Australia

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 August 2024 in EMBO Reports
Verified
Journal Article
Open access
AKAishwarya Kulkarni
Aishwarya Kulkarni
VMVarshini Mohan
Varshini Mohan
TTTracy T Tang
Tracy T Tang
LPLeonard Post
Leonard Post
YCYih-Chih Chan
Yih-Chih Chan
KHKieran F Harvey
Kieran F Harvey
The Hippo tumor suppressor pathway controls transcription by regulating nuclear abundance of YAP and TAZ, which activate transcription with the TEAD1-TEAD4 DNA-binding proteins. Recently, several small-molecule inhibitors of YAP and TEADs have been reported, with some entering clinical trials for different cancers with Hippo pathway deregulation, most notably, mesothelioma. Using genome-wide CRISPR/Cas9 screens we reveal that mutations in genes from the Hippo, MAPK, and JAK-STAT signaling pathways all modulate the response of mesothelioma cell lines to TEAD palmitoylation inhibitors. By exploring gene expression programs of mutant cells, we find that MAPK pathway hyperactivation confers resistance to TEAD inhibition by reinstating expression of a subset of YAP/TAZ target genes. Consistent with this, combined inhibition of TEAD and the MAPK kinase MEK, synergistically blocks proliferation of multiple mesothelioma and lung cancer cell lines and more potently reduces the growth of patient-derived lung cancer xenografts in vivo. Collectively, we reveal mechanisms by which cells can overcome small-molecule inhibition of TEAD palmitoylation and potential strategies to enhance the anti-tumor activity of emerging Hippo pathway targeted therapies.

9 July 2021
Verified
Conference Paper
Closed access
AKAishwarya S Kulkarni
Aishwarya S Kulkarni
NENaresh E
Naresh E
MSMerla Swetha
Merla Swetha
SKS.M Kusuma
S.M Kusuma
One among the curses in the education institution of the country is malpractice during written examination, either online or off line. Some of the suspicious activities during written examination includes, copying from neighbouring candidates, other written materials, exchange of answer scripts, etc. These activities lead to physical movement of the face and other parts of the body than the normal writing posture of the candidate(s) seen at the initial stage of the examination. Any deviation to normal posture can be an indicative of suspicious activities. Main objective of this work is to build a real time edge computing-based video analytics and techniques to identify the suspicious activities relating to malpractice case booking as evidence and proofs during written examination. The proposed model includes a low-cost webcam video frame capturing and edge computing for analytics to detect the face and behaviour recognition using the following techniques. Firstly, the CNN is used to detect human faces. Secondly, candidates are recognised using YOLO and features are extracted using Local Binary Patterns Histogram (LBPH). After feature extraction, the activity classification is performed and is used to detect whether the activity is suspicious or not based on the face movement, hand contact detection and body posture using SVM. Lastly, the system will set an alert based on the threshold set for movement pattern of the candidate(s) in the given area focussed by the web cam or any other camera used in an examination centre or for individual online examination for suspicious activities.

16 August 2023 in bioRxiv
Verified
Preprint
Open access
PDF file
AKAishwarya Kulkarni
Aishwarya Kulkarni
VMVarshini Mohan
Varshini Mohan
TTTracy T. Tang
Tracy T. Tang
LPLeonard Post
Leonard Post
MMMurray Manning
Murray Manning
KHKieran F. Harvey
Kieran F. Harvey
The Hippo tumour suppressor pathway controls transcription by regulating nuclear abundance of YAP and TAZ, which activate transcription with the TEAD1-TEAD4 DNA-binding proteins. Recently, several small-molecule inhibitors of YAP and TEADs have been reported, with some now entering clinical trials for different cancers. Here, we investigated the cellular response to TEAD palmitoylation inhibitors, using a combination of genomic and genetic strategies. Genome-wide CRISPR/Cas9 screens identified genes that modulate the cellular response to TEAD inhibition, including members of the Hippo, MAPK and JAK-STAT signaling pathways. By exploring gene expression programs of mutant cells, we found that MAPK pathway hyperactivation confers resistance to TEAD inhibition by reinstating expression of a subset of YAP/TEAD target genes. Consistent with this, combined inhibition of TEAD and the MAPK protein MEK, synergistically blocked proliferation of several mesothelioma and lung cancer cell lines and more potently reduced the growth of patient-derived lung cancers in vivo. Collectively, we reveal mechanisms by which cells can overcome small-molecule inhibition of TEADs and potential strategies to enhance the anti-tumor activity of emerging Hippo pathway targeted therapies.